Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats

Journal of Hypertension

Volumn 20, Issue 6, 2002, Pages 1127-1134

  Touyz, Rhian M ^a   Deschepper, Christian ^a   Park, Jeong Bae ^a   He, Gang ^a   Chen, Xin ^a   Neves, Mario Fritsch T ^a   Virdis, Agostino ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Blood vessels; Hypertension; Mitogen activated protein kinases; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; MITOGEN ACTIVATED PROTEIN KINASE; ANGIOTENSIN II; ENZYME INHIBITOR; FLAVONOID; VASOCONSTRICTOR AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HYPERTENSION; MESENTERIC ARTERY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY; VASCULAR ENDOTHELIUM; VASODILATATION; WESTERN BLOTTING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; VASCULAR RESISTANCE; VASOCONSTRICTION; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FLAVONOIDS; HYPERTENSION; MESENTERIC ARTERIES; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0036591592     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200206000-00024     Document Type: Article

References (42)

1. Structure and function of small arteries
2. Reactivity of small blood vessels in hypertension: Relationship with structural changes
3. Mechanical influences on vascular smooth cell function
4. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
5. Angiotensin II signal transduction in vascular smooth muscle. Role of tyrosine kinases
6. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology
7. MAP kinase pathways
8. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries
9. Mitogen-activated protein kinase activation: An alternate signaling pathway for sustained vascular smooth muscle contraction
10. 5-Hydroxytryptamine-induced potentiation of ET-1 and norepinephrine-induced contraction is MAP kinase pathway dependent
11. MEK inhibition attenuates Ang II-mediated signaling and contraction in SHR vascular smooth muscle cells
12. Differential activation of ERK1/2 and p38MAP kinase by angiotensin II type I receptor in vascular smooth muscle cells from WKY and SHR
13. 2+ transient in vascular smooth muscle cell from WKY and SHR
14. Growth factors and ERK in vascular smooth muscle cells of normotensive and spontaneously hypertensive rats
15. Angiotensin II responses of vascular smooth muscle cells from hypertensive rats: Enhancement at the level of p42 and p44 mitogen activated protein kinase
16. Different activation of vascular MAP kinases in SHR and DOCA-salt hypertensive rats
17. Acute hypertension activates mitogen-activated protein kinases in arterial wall
18. Chronic activation of glomerular MAP kinases in Dahl salt-sensitive rats
19. Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries
20. Activation of glomerular mitogen-activated protein kinases in angiotensin II-mediated hypertension
21. 2-terminal activities are continuously and differentially increased in aorta of hypertensive rats
22. A synthetic inhibitor of the mitogen-activated protein kinase cascade
23. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan
24. 2 receptors in angiotensin II-stimulated contraction of small arteries in youg SHR
25. Growth factors and mitogen-activated protein kinases
26. A role for MAP kinase in differentiated smooth muscle contraction evoked by alpha-adrenoceptor stimulation
27. 2+-calmodulin-dependent kinase II-dependent activation of contractility in ferret aorta
28. Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle
29. Dysregulation of Ang II-activated c-Src is an important upstream mediator of enhanced ERK1/2-dependent growth signaling in vascular smooth muscle cells from hypertensive patients
30. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells
31. Protein tyrosine phosphatases in the vessel wall. Counter-part to the tyrosine kinases
32. Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension
33. Pulsatile stretch-induced extracellular signal-regulated kinase 1/2 activation in organ culture of rabbit aorta involves reactive oxygen species
34. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice
35. Nonspecific inhibition of myogenic tone by PD98059, a MEK1 inhibitor, in rat middle cerebral arteries
36. Ang II-stimulated generation of reactive oxygen species in human vascular smooth cells is mediated via PLD-dependent pathways
37. NAD(P)H oxidase and vascular function
38. Reactive oxygen species as mediators of signal transduction in cardiovascular disease
39. Endothelial function and oxidant stress
40. Relevance of endothelium-derived hyperpolarizing factor in the effects of hypertension on rat coronary relaxations
41. Renin-angiotensin system blockade improves endothelial dysfunction in hypertension
42. Contribution of mitogen activated protein kinase to vascular contraction in hypertension